Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01964430
Brief Title: Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) (apact)

First Submitted : October 14, 2013
First Submitted that Met QC Criteria : October 14, 2013
First Posted : October 17, 2013 (Estimate)

Results First Submitted : December 17, 2019
Results First Submitted that Met QC Criteria : December 17, 2019
Results First Posted : January 6, 2020

Last Update Submitted that Met QC Criteria : April 7, 2020
Last Update Posted : April 16, 2020